QRHXD and MTX significantly reduced toe swelling and arthritis (Figures 5A, B), decreased inflammatory factors such as IL-1β, IL-6, IL-17, and TNF-α, and increased the anti-inflammatory factor IL-10 (Figures 5C–G). This evidence concerns the gene IL17A and arthritic joint disease.